These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9009097)

  • 41. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia.
    Guyotat D; Wahbi K; Viallet A; Piselli S; Campos L
    Leukemia; 1999 Jul; 13(7):991-8. PubMed ID: 10400413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears.
    Cabot GP; Bentz M; Scholl C; Moos M; Fischer K; Lichter P; Döhner H
    Cancer Genet Cytogenet; 1996 Apr; 87(2):107-11. PubMed ID: 8625254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
    Broughton CM; Sherrington P; Pender NT; Clark RE
    Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.
    Baines P; Austin S; Fisher J; Owen-Jones E; Lee-Jones L; Throp D; Mckinley M; Hoy T; Mills K; Thompson P; Burnett A
    Leuk Res; 2002 Nov; 26(11):997-1005. PubMed ID: 12363468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH; Beelen DW; Opalka B; Seeber S; Schaefer UW
    Ann Hematol; 2000 Aug; 79(8):424-31. PubMed ID: 10985361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Application of interphase fluorescence in situ hybridization for determination of the tumor load in chronic myeloid leukemia].
    Du QF; Zhou SY; Liu XL; Song LL; Zhang Y
    Ai Zheng; 2003 Jun; 22(6):612-5. PubMed ID: 12948411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
    Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
    Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification.
    Pachmann K; Zhao S; Schenk T; Kantarjian H; El-Naggar AK; Siciliano MJ; Guo JQ; Arlinghaus RB; Andreeff M
    Br J Haematol; 2001 Mar; 112(3):749-59. PubMed ID: 11260080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
    Dickinson AM; Middleton SL; Latham J; Dunn J; Thomas L; Proctor SJ
    Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia.
    Keating A; Wang XH; Laraya P
    Blood; 1994 Apr; 83(7):1744-9. PubMed ID: 8142641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Detection of tumor load in chronic myeloid leukemia during treatment with transplantation by conventional cytogenetics, nested-RT-PCR and FISH].
    Wang HP; Li GX; Qiao ZH; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):237-41. PubMed ID: 17493323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
    Issaad C; Vainchenker W
    Blood; 1994 Nov; 84(10):3447-56. PubMed ID: 7524739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.